scholarly journals Collaborative Study for Analysis of Subvisible Particles Using Flow Imaging and Light Obscuration: Experiences in Japanese Biopharmaceutical Consortium

2019 ◽  
Vol 108 (2) ◽  
pp. 832-841 ◽  
Author(s):  
Masato Kiyoshi ◽  
Hiroko Shibata ◽  
Akira Harazono ◽  
Tetsuo Torisu ◽  
Takahiro Maruno ◽  
...  
2019 ◽  
Vol 20 (3) ◽  
pp. 232-244 ◽  
Author(s):  
Zahir S. Akhunzada ◽  
Mario Hubert ◽  
Erinc Sahin ◽  
James Pratt

Background:The presence of subvisible particles (SVPs) in parenteral formulations of biologics is a major challenge in the development of therapeutic protein formulations. Distinction between proteinaceous and non-proteinaceous SVPs is vital in monitoring formulation stability.Methods:The current compendial method based on light obscuration (LO) has limitations in the analysis of translucent/low refractive index particles. A number of attempts have been made to develop an unambiguous method to characterize SVPs, albeit with limited success.Results:Herein, we describe a robust method that characterizes and distinguishes both potentially proteinaceous and non-proteinaceous SVPs in protein formulations using Microflow imaging (MFI) in conjunction with the MVAS software (MFI View Analysis Suite), developed by ProteinSimple. The method utilizes two Intensity parameters and a morphological filter that successfully distinguishes proteinaceous SVPs from non-proteinaceous SVPs and mixed aggregates.Conclusion:he MFI generated raw data of a protein sample is processed through Lumetics LINK software that applies an in-house developed filter to separate proteinaceous from the rest of the particulates.


2019 ◽  
Vol 108 (7) ◽  
pp. 2397-2405 ◽  
Author(s):  
Anja Matter ◽  
Atanas Koulov ◽  
Satish Singh ◽  
Hanns-Christian Mahler ◽  
Helena Reinisch ◽  
...  

2015 ◽  
Vol 87 (12) ◽  
pp. 6119-6124 ◽  
Author(s):  
Anacelia Ríos Quiroz ◽  
Gabriela Québatte ◽  
Fabian Stump ◽  
Christof Finkler ◽  
Joerg Huwyler ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document